Multiple Vitamin Deficiencies Additively Increase the Risk of Incident Fractures in Japanese Postmenopausal Women

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2018 Nov 29

PMID 30483849

Citations 8

Authors

T Kuroda

K Uenishi

H Ohta

M Shiraki

Affiliations

Soon will be listed here.

Abstract

Introduction: To evaluate the associations of multiple vitamin deficiencies on incident fractures, the relationships between serum vitamin markers and incident bone fractures were investigated in Japanese postmenopausal women.

Methods: This analysis used a subset of the ongoing cohort maintained by a primary care institution. Inclusion criteria of the present study were postmenopausal women aged ≥ 50 years, without vitamin supplementation and secondary osteoporosis. Baseline serum concentrations of 25-hydroxyvitamin D (25(OH)D), undercarboxylated osteocalcin (ucOC), and homocysteine (Hcy) were measured to assess vitamin D, vitamin K, and vitamin B, respectively. Since 25(OH) D positively relates to vitamin D, ucOC and Hcy negatively relate to vitamin K and vitamin B nutrients, respectively, the subjects with lower (25(OH)D) or higher (ucOC or Hcy) values than each median value was defined as subjects with the corresponding vitamin deficiency. Subjects were divided into four groups according to the number of deficiency: no deficiency, single deficiency, double deficiencies, and triple deficiencies. Relationships between the vitamin deficiencies and incident fractures were evaluated by Cox regression analysis.

Results: A total of 889 subjects were included in this analysis; their mean and SD age was 68.3 ± 9.5 years, and the follow-up period was 6.3 ± 5.1 years. The numbers of subjects in the four groups were 139 (15.6%), 304 (34.2%), 316 (35.5%), and 130 (14.6%) for the groups with no, single, double, and triple deficiencies, respectively. Incident fractures were observed in 264 subjects (29.7%) during the observation period. The number of deficiencies was significantly associated with incident fracture (hazard ratio 1.25, 95% confidence interval 1.04-1.50, P = 0.018) after adjustment for possible confounding factors including the treatment of osteoporosis.

Conclusion: Accumulation of vitamin deficiencies was related to incident fractures.

Citing Articles

Vitamin D insufficiency and disease risk in the elderly.

Tanaka K, Ao M, Tamaru J, Kuwabara A J Clin Biochem Nutr. 2024; 74(1):9-16.

PMID: 38292127 PMC: 10822750. DOI: 10.3164/jcbn.23-59.

PIVKA‑II is associated with liver function, bone metabolism, and muscle function in patients with liver disease.

Honda T, Ichikawa T, Yamashima M, Yamamichi S, Koike M, Nakano Y Biomed Rep. 2024; 20(1):2.

PMID: 38222867 PMC: 10784875. DOI: 10.3892/br.2023.1690.

Endocrine modulation of brain-skeleton axis driven by neural stem cell-derived perilipin 5 in the lipid metabolism homeostasis for bone regeneration.

Kong L, Zhao H, Wang F, Zhang R, Yao X, Zuo R Mol Ther. 2023; 31(5):1293-1312.

PMID: 36760127 PMC: 10188646. DOI: 10.1016/j.ymthe.2023.02.004.

Distinct dietary risk factors for incident osteoporotic fractures in early and late postmenopausal phase women.

Nakano M, Uenishi K, Nakamura Y, Takahashi J, Shiraki M J Bone Miner Metab. 2023; 41(2):227-238.

PMID: 36715763 DOI: 10.1007/s00774-023-01400-7.

Suboptimal Plasma Vitamin C Is Associated with Lower Bone Mineral Density in Young and Early Middle-Aged Men: A Retrospective Cross-Sectional Study.

Lan K, Wang L, Lin Y, Hung K, Wu L, Ho C Nutrients. 2022; 14(17).

PMID: 36079812 PMC: 9459983. DOI: 10.3390/nu14173556.

References

Matsunaga S, Ito H, Sakou T . The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int. 1999; 65(4):285-9. DOI: 10.1007/s002239900700. View

Vermeer C, Braam L . Role of K vitamins in the regulation of tissue calcification. J Bone Miner Metab. 2001; 19(4):201-6. DOI: 10.1007/s007740170021. View

Kado D, Bucur A, Selhub J, Rowe J, Seeman T . Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging. Am J Med. 2002; 113(7):537-42. DOI: 10.1016/s0002-9343(02)01269-x. View

Visser M, Deeg D, Lips P . Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003; 88(12):5766-72. DOI: 10.1210/jc.2003-030604. View

van Meurs J, Dhonukshe-Rutten R, Pluijm S, van der Klift M, de Jonge R, Lindemans J . Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004; 350(20):2033-41. DOI: 10.1056/NEJMoa032546. View

McLean R, Jacques P, Selhub J, Tucker K, Samelson E, Broe K . Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004; 350(20):2042-9. DOI: 10.1056/NEJMoa032739. View

Lock C, Lecouturier J, Mason J, Dickinson H . Lifestyle interventions to prevent osteoporotic fractures: a systematic review. Osteoporos Int. 2005; 17(1):20-8. DOI: 10.1007/s00198-005-1942-0. View

Cockayne S, Adamson J, Lanham-New S, Shearer M, Gilbody S, Torgerson D . Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166(12):1256-61. DOI: 10.1001/archinte.166.12.1256. View

Kuo H, Liao K, Leveille S, Bean J, Yen C, Chen J . Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults. J Gerontol A Biol Sci Med Sci. 2007; 62(4):434-9. PMC: 2362390. DOI: 10.1093/gerona/62.4.434. View

10.

Vester B, Rasmussen K . High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem. 1991; 29(9):549-54. DOI: 10.1515/cclm.1991.29.9.549. View

11.

Tsugawa N, Shiraki M, Suhara Y, Kamao M, Ozaki R, Tanaka K . Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab. 2007; 26(1):79-85. DOI: 10.1007/s00774-007-0790-8. View

12.

Cheung A, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J . Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med. 2008; 5(10):e196. PMC: 2566998. DOI: 10.1371/journal.pmed.0050196. View

13.

Shiraki M, Urano T, Kuroda T, Saito M, Tanaka S, Miyao-Koshizuka M . The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures. J Bone Miner Metab. 2008; 26(6):595-602. DOI: 10.1007/s00774-008-0878-9. View

14.

Kuroda T, Shiraki M, Tanaka S, Ohta H . Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone. 2008; 44(1):168-72. DOI: 10.1016/j.bone.2008.03.023. View

15.

Dawson-Hughes B, Mithal A, Bonjour J, Boonen S, Burckhardt P, Fuleihan G . IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010; 21(7):1151-4. DOI: 10.1007/s00198-010-1285-3. View

16.

Okazaki R, Sugimoto T, Kaji H, Fujii Y, Shiraki M, Inoue D . Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D₃ load in Japanese subjects. J Bone Miner Metab. 2010; 29(1):103-10. DOI: 10.1007/s00774-010-0200-5. View

17.

Scott D, Blizzard L, Fell J, Ding C, Winzenberg T, Jones G . A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol (Oxf). 2010; 73(5):581-7. DOI: 10.1111/j.1365-2265.2010.03858.x. View

18.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

19.

Apalset E, Gjesdal C, Eide G, Tell G . Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study. Bone. 2011; 49(5):990-5. DOI: 10.1016/j.bone.2011.07.035. View

20.

Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N . Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab. 2013; 31(3):247-57. DOI: 10.1007/s00774-013-0447-8. View